2m 2m 2m 2m 2m 2m 2m
NEUROSENSE (NRSN)
NASDAQ
$0.73-$0.004 (-0.55%)
Price as of Jul 13, 2026 7:31 PM EDT- N/AMarket Cap
- -63.50%1-Year Change
- BiotechnologyIndustry
NEUROSENSE (NRSN)
$0.73-$0.004 (-0.55%)
NRSN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.73 | ||
Change | +$0.001 (+0.21%) | ||
Open | $0.73 | ||
High | $0.73 | ||
Low | $0.71 | ||
Previous Close | $0.73 | ||
Volume | 71,461 | ||
30-Day Average Volume | 212,339 | ||
1-Week Change | 4.89% | ||
1-Month Change | -0.71% | ||
1-Year Change | -63.50% | ||
3-Year Change | -46.72% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 32.6M | ||
Total Assets | $1.0M | ||
Market Cap | N/A | ||
Enterprise Value | N/A | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue